熔点	195-197 ºC
密度	1.226

没有数据	没有数据

来源	SDS样本
没有数据	没有数据

产品合成路线

更多

名称	CAS号

更多

文章

同行评议文献

Synthesis and antiplasmodial activity of novel 2,4-diaminopyrimidines.Derek C Martyn et al.Bioorganic & medicinal chemistry letters, 20(1), 228-231 (2009-11-17) New insights into the structural requirements for pro-apoptotic agents based on 2,4-diaminoquinazoline, 2,4-diaminopyrido[2,3-d]pyrimidine and 2,4-diaminopyrimidine derivatives.María Font et al.European journal of medicinal chemistry, 46(9), 3887-3899 (2011-06-28) In vitro biological activity and structural analysis of 2,4-diamino-5-(2'-arylpropargyl)pyrimidine inhibitors of Candida albicans.Janet L Paulsen et al.Bioorganic & medicinal chemistry, 17(14), 4866-4872 (2009-06-30) The acyclic 2,4-diaminopyrimidine nucleoside phosphonate acts as a purine mimetic in HIV-1 reverse transcriptase DNA polymerization.Brian D Herman et al.The Journal of biological chemistry, 285(16), 12101-12108 (2010-02-19) 2,4-diaminopyrimidine derivatives as potent growth hormone secretagogue receptor antagonists.Michael D Serby et al.Journal of medicinal chemistry, 49(8), 2568-2578 (2006-04-14) Hydrogen-bonded supramolecular structures in co-crystals of ?-or ?-diketone enols with 2, 6-diaminopyridine or 2, 4-diaminopyrimidine.Bertolasi V, et al. New. J. Chem., 26(11), 1559-1566 (2002) Effect of substituents on the excited-state dynamics of the modified DNA bases 2,4-diaminopyrimidine and 2,6-diaminopurine.Zsolt Gengeliczki et al.Physical chemistry chemical physics : PCCP, 12(20), 5375-5388 (2010-04-10) Structure of 2,4-diaminopyrimidine-theobromine alternate base pairs.Zsolt Gengeliczki et al.The journal of physical chemistry. A, 115(41), 11423-11427 (2011-09-06) Modeling of the growth hormone secretagogue receptor antagonistic activity using chemometric tools.Susheela Sharma et al.Journal of enzyme inhibition and medicinal chemistry, 24(4), 1024-1033 (2009-06-25) Efficient preparation of 2,4-diaminopyrimidine nucleosides: total synthesis of lysidine and agmatidine.Brett J Kopina et al.Organic letters, 14(16), 4118-4121 (2012-08-01) 2,4-Diaminopyrimidine MK2 inhibitors. Part I: Observation of an unexpected inhibitor binding mode.Maria A Argiriadi et al.Bioorganic & medicinal chemistry letters, 20(1), 330-333 (2009-11-19) Fused bicyclic derivatives of 2,4-diaminopyrimidine as c-Met inhibitors.Linda R Weinberg et al.Bioorganic & medicinal chemistry letters, 21(1), 164-167 (2010-12-03) Cocrystals of 6-methyl-2-thiouracil: presence of the acceptor-donor-acceptor/donor-acceptor-donor synthon.Wilhelm Maximilian Hützler et al.Acta crystallographica. Section C, Structural chemistry, 71(Pt 3), 229-238 (2015-03-04) Contribution of nitric oxide-dependent guanylate cyclase and reactive oxygen species signaling pathways to desensitization of μ-opioid receptors in the rat locus coeruleus.Patricia Pablos et al.Neuropharmacology, 99, 422-431 (2015-08-10) Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.C R Bourne et al.Antimicrobial agents and chemotherapy, 54(9), 3825-3833 (2010-07-08) Novel 2,3,4,5-tetrahydro-benzo[d]azepine derivatives of 2,4-diaminopyrimidine, selective and orally bioavailable ALK inhibitors with antitumor efficacy in ALCL mouse models.Eugen F Mesaros et al.Bioorganic & medicinal chemistry letters, 21(1), 463-466 (2010-11-16) Design and optimization of hybrid of 2,4-diaminopyrimidine and arylthiazole scaffold as anticancer cell proliferation and migration agents.Wenbo Zhou et al.European journal of medicinal chemistry, 96, 269-280 (2015-04-23) 2,4-Diaminopyrimidine MK2 inhibitors. Part II: Structure-based inhibitor optimization.Christopher M Harris et al.Bioorganic & medicinal chemistry letters, 20(1), 334-337 (2009-11-21) Development of 2,4-diaminopyrimidine derivatives as novel SNSR4 antagonists.Malken Bayrakdarian et al.Bioorganic & medicinal chemistry letters, 21(7), 2102-2105 (2011-02-22) Improvement in oral bioavailability of 2,4-diaminopyrimidine c-Met inhibitors by incorporation of a 3-amidobenzazepin-2-one group.Karen L Milkiewicz et al.Bioorganic & medicinal chemistry, 19(21), 6274-6284 (2011-10-05) In pursuit of virtual lead optimization: the role of the receptor structure and ensembles in accurate docking.Erin S D Bolstad et al.Proteins, 73(3), 566-580 (2008-05-14) Synthesis and biological activity of substituted 2,4-diaminopyrimidines that inhibit Bacillus anthracis.Baskar Nammalwar et al.European journal of medicinal chemistry, 54, 387-396 (2012-06-19) Evidence for dynamics in proteins as a mechanism for ligand dissociation.Mary J Carroll et al.Nature chemical biology, 8(3), 246-252 (2012-01-17) Inhibitory activities of three classes of acyclic nucleoside phosphonates against murine polyomavirus and primate simian virus 40 strains.Ilya Lebeau et al.Antimicrobial agents and chemotherapy, 51(6), 2268-2273 (2007-04-11) Ultra performance liquid chromatography tandem mass spectrometry performance evaluation for analysis of antibiotics in natural waters.Fatima Tamtam et al.Analytical and bioanalytical chemistry, 393(6-7), 1709-1718 (2009-01-17) Synthesis of pyrimidines and triazines in ice: implications for the prebiotic chemistry of nucleobases.César Menor-Salván et al.Chemistry (Weinheim an der Bergstrasse, Germany), 15(17), 4411-4418 (2009-03-17) Methanesulfonamido-cyclohexylamine derivatives of 2,4-diaminopyrimidine as potent ALK inhibitors.Craig A Zificsak et al.Bioorganic & medicinal chemistry letters, 21(13), 3877-3880 (2011-06-03) 2,4-Diaminopyrimidines as potent inhibitors of Trypanosoma brucei and identification of molecular targets by a chemical proteomics approach.Luke Mercer et al.PLoS neglected tropical diseases, 5(2), e956-e956 (2011-02-25) 2,4-Diaminopyrimidine inhibitors of c-Met kinase bearing benzoxazepine anilines.Craig A Zificsak et al.Bioorganic & medicinal chemistry letters, 21(2), 660-663 (2010-12-31) Discovery of 6-ethyl-2,4-diaminopyrimidine-based small molecule renin inhibitors.Daniel D Holsworth et al.Bioorganic & medicinal chemistry letters, 17(13), 3575-3580 (2007-05-08)

备注